EQRxNews Page EQRx Appoints Jami Rubin as Chief Financial Officer and Kent Rogers as Chief Customer Officer EQRx, a company committed to developing and delivering important new medicines at lower prices, today…Arboretum_JDApril 19, 2021
EQRxNews Page EQRx’s partner, Hansoh Pharmaceuticals, Releases Topline Results of their Phase III Study for Aumolertinib EQRx, a company committed to developing and delivering important new medicines at lower prices, announced…Arboretum_JDFebruary 22, 2021
EQRxHome PageNews Page EQRx Scales Disruptive Model of Important New Medicines at Lower Prices with $500M Series B Financing EQRx, a company committed to developing and delivering important new medicines at lower prices, today…Arboretum_JDJanuary 11, 2021
EQRxNews Page EQRx and CStone Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors CStone Pharmaceuticals recently announced an agreement to out-license ex-Greater China rights for two key late-stage…Arboretum_JDOctober 28, 2020
EQRxNews Page EQRx Selected as One of Fierce Biotech’s 2020 Fierce 15 Unlike the typical Fierce 15, EQRx isn’t yet looking for major innovation in the R&D…Arboretum_JDSeptember 30, 2020
EQRxHome PageNews Page Arboretum Invests in EQRx, a First-of-its-Kind Biopharmaceutical Company EQRx announced today that it is launching to create novel, patent-protected medicines at prices that…Arboretum_JDJanuary 13, 2020